Relationship between a glycoprotein acting as lipoprotein lipase inhibitor and arteriosclerosis.
D000328:Adult; D000818:Animals; D001011:Aorta / Q000201:enzymology; D001161:Arteriosclerosis / Q000097:blood / Q000201:enzymology*; D001808:Blood Vessels / Q000033:anatomy & histology / Q000187:drug effects; D001921:Brain / Q000201:enzymology; D004285:Dogs; D004586:Electrophoresis; D006023:Glycoproteins / Q000097:blood / Q000302:isolation & purification / Q000494:pharmacology*; D006801:Humans; D007106:Immune Sera; D007122:Immunoelectrophoresis; D066298:In Vitro Techniques; D007273:Injections, Intramuscular; D007525:Isoelectric Focusing; D007668:Kidney / Q000201:enzymology; D008071:Lipoprotein Lipase / Q000032:analysis / Q000037:antagonists & inhibitors* / Q000097:blood; D008074:Lipoproteins / Q000378:metabolism; D008099:Liver / Q000201:enzymology; D008297:Male; D009206:Myocardium / Q000201:enzymology; D051381:Rats
D006023:Glycoproteins; D007106:Immune Sera; D008074:Lipoproteins; D008071:Lipoprotein Lipase